Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sticky patch could catch hidden heart problem after stroke

NCT ID NCT07295769

Diagnosis Sponsor: Asan Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wearable ECG patch (MEMO Patch) to see if it can detect atrial fibrillation—a heart rhythm issue that raises stroke risk—in 100 people who had a stroke with no known cause. Participants wear the patch for up to 14 days at home, and results are compared with standard monitoring. The goal is to find a simpler, non-invasive way to diagnose hidden heart problems and guide treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants may take part in this clinical study only if they meet all of the following criteria: 1. Adults aged 19 years or older who voluntarily provide written informed consent to participate in the study 2. Patients diagnosed with ESUS (Embolic Stroke of Undetermined Source) 3. Patients who require in-hospital or out-of-hospital electrocardiographic (ECG) monitoring Exclusion Criteria: Participants who meet any of the following criteria cannot be enrolled in this clinical study: 1. Individuals already diagnosed with atrial fibrillation or atrial flutter 2. Individuals with a clearly identified cause of stroke 3. Individuals known to have allergic reactions to adhesives or hydrogels 4. Individuals who, in the investigator's judgment, have cognitive vulnerability that makes it difficult to understand the study information and voluntarily decide on participation 5. Any other individuals whom the principal investigator considers to be at potential risk by participating in the study or otherwise unsuitable for participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Embolic stroke of undetermined source are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

intracranial embolism stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Embolic stroke of undetermined source

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asan Medical Center

    RECRUITING

    Seoul, Songpa-gu, 05505, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.